Trials / Conditions / Cutaneous Melanoma, Stage III
Cutaneous Melanoma, Stage III
7 registered clinical trials studyying Cutaneous Melanoma, Stage III — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Neo-adjuvant Immunotherapy in Patients With Localized Melanoma NCT07230613 | UNICANCER | Phase 2 |
| Recruiting | Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma NCT07148245 | University of California, San Francisco | — |
| Recruiting | The Multicentre Selective Lymphadenectomy Trial - 3 NCT07049276 | Melanoma Institute Australia | N/A |
| Active Not Recruiting | Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Thera NCT03719131 | Emory University | Phase 2 |
| Completed | pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma NCT03655756 | TuHURA Biosciences, Inc. | EARLY_Phase 1 |
| Completed | Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma NCT03541148 | Catalysis SL | Phase 2 |
| Available | IFx-Hu2.0 Expanded Access Program NCT04853602 | TuHURA Biosciences, Inc. | — |